CX Institutional Purchases 3,083 Shares of Select Medical Holdings Co. (NYSE:SEM)

CX Institutional grew its stake in Select Medical Holdings Co. (NYSE:SEM) by 8.9% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 37,904 shares of the health services provider’s stock after purchasing an additional 3,083 shares during the period. CX Institutional’s holdings in Select Medical were worth $714,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently modified their holdings of SEM. GAMMA Investing LLC boosted its holdings in Select Medical by 16.6% during the 3rd quarter. GAMMA Investing LLC now owns 2,313 shares of the health services provider’s stock valued at $81,000 after acquiring an additional 330 shares during the period. KBC Group NV boosted its holdings in Select Medical by 4.5% during the 3rd quarter. KBC Group NV now owns 13,050 shares of the health services provider’s stock valued at $455,000 after acquiring an additional 563 shares during the period. Swiss National Bank boosted its holdings in Select Medical by 0.4% during the 3rd quarter. Swiss National Bank now owns 215,900 shares of the health services provider’s stock valued at $7,528,000 after acquiring an additional 800 shares during the period. Quarry LP purchased a new position in Select Medical during the 3rd quarter valued at $30,000. Finally, Canada Pension Plan Investment Board purchased a new position in Select Medical during the 2nd quarter valued at $39,000. Hedge funds and other institutional investors own 89.48% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts recently issued reports on SEM shares. StockNews.com cut Select Medical from a “buy” rating to a “hold” rating in a report on Wednesday, January 15th. Benchmark cut Select Medical from a “buy” rating to a “hold” rating in a report on Monday, November 25th. Royal Bank of Canada boosted their price target on Select Medical from $40.00 to $47.00 and gave the stock an “outperform” rating in a research report on Monday, November 4th. Finally, UBS Group reduced their price target on Select Medical from $40.00 to $21.00 and set a “neutral” rating for the company in a research report on Friday, January 3rd. Three investment analysts have rated the stock with a hold rating and two have given a buy rating to the company. According to MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $39.50.

Select Medical Stock Up 2.1 %

Select Medical stock opened at $19.69 on Friday. The company has a debt-to-equity ratio of 1.37, a quick ratio of 1.13 and a current ratio of 1.13. The business’s 50-day simple moving average is $21.64 and its two-hundred day simple moving average is $30.51. The company has a market cap of $2.55 billion, a PE ratio of 9.20, a PEG ratio of 0.65 and a beta of 1.45. Select Medical Holdings Co. has a fifty-two week low of $18.02 and a fifty-two week high of $40.98.

Select Medical (NYSE:SEM) last issued its earnings results on Thursday, October 31st. The health services provider reported $0.43 EPS for the quarter, topping analysts’ consensus estimates of $0.36 by $0.07. Select Medical had a return on equity of 15.99% and a net margin of 3.97%. The firm had revenue of $1.76 billion for the quarter, compared to the consensus estimate of $1.74 billion. During the same quarter in the prior year, the business earned $0.46 earnings per share. The company’s revenue was up 5.7% compared to the same quarter last year. Equities analysts anticipate that Select Medical Holdings Co. will post 1.97 EPS for the current year.

Select Medical Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, November 26th. Stockholders of record on Wednesday, November 13th were paid a $0.125 dividend. The ex-dividend date of this dividend was Wednesday, November 13th. This represents a $0.50 dividend on an annualized basis and a dividend yield of 2.54%. Select Medical’s payout ratio is 23.36%.

Insider Transactions at Select Medical

In other Select Medical news, Director Marilyn B. Tavenner sold 32,000 shares of the stock in a transaction that occurred on Tuesday, November 26th. The stock was sold at an average price of $21.09, for a total transaction of $674,880.00. Following the transaction, the director now owns 22,000 shares in the company, valued at approximately $463,980. This represents a 59.26 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, VP Robert G. Breighner, Jr. sold 4,989 shares of the stock in a transaction that occurred on Wednesday, December 4th. The stock was sold at an average price of $19.95, for a total value of $99,530.55. Following the transaction, the vice president now owns 30,356 shares in the company, valued at $605,602.20. This represents a 14.12 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 19.14% of the company’s stock.

Select Medical Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.